The new edition of this best-selling report offers insight into the manufacturing process, strategy, issues and drivers from an expert author.
Manufacturing in the Global Pharmaceuticals Industry - Key drivers, company strategies and regulations (3rd ed) is the only report available that covers this crucial area of the pharmaceutical industry in such depth. The concentration in recent years on creating organisations that are market or customer-led, or research-driven has taken the focus away from the manufacturing process, although it is clear that the most successful organisations integrate all these activities to remain market leaders.
Global pharmaceutical manufacturing is in a state of flux. There is excess capacity in manufacturing facilities for finished dosage forms and a shortfall for biotechnology manufacturing. The situation in APIs is not so clear-cut, and the trend for multinationals to grow through M & A has led to the need to rationalise facilities. Meanwhile, local companies from emerging markets wishing to expand into new markets and exporting must be able to satisfy ever more stringent quality standards.
This report tackles the challenges of manufacturing in a global marketplace by providing unique insight into the strategies a successful company will adopt. By using examples, case studies and scenarios to aid clarification of the more technical aspects of the manufacturing process, you can be assured your desisions are made with full understanding of the key issues.
This timely third edition will enable you to:
Assess the pros and cons of outsourcing manufacturing functions and develop key strategies to effectively measure supplier and contractor performance
Understand and prepare for the latest regulations applicable to manufacturing and their variations globally
Develop strategies to effectively manage contractor relationships
Understand the definitions used in validation, and how extra investment in validation will improve performance
Build competencies for manufacturing that meet the objectives of: speed of delivery, reduction in product cost, overall quality, optimisation of capital spend, maintenance of customer inventory, minimisation of regulatory impact, optimisation in the number of manfacturing sites, maintenance of strategic sourcing for disaster management planning
Understand the 'New Paradigm' in international manufacturing and how it relates to the pharmaceutical industry.
Use this report help with:
Planning a global manfacturing strategy
Regulations and quality assurance issues
The 'New Paradigm' in manufacturing
The key drivers and changes in today's manufacturing environment
Making the right investment decision
(0 items)
